Sunesis to Present at the 2013 Wedbush Life Sciences Management Access Conference

        Print
| Source: Sunesis Pharmaceuticals, Inc.

SOUTH SAN FRANCISCO, Calif., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Eric Bjerkholt, Executive Vice President, Corporate Development and Finance, Chief Financial Officer at Sunesis, will be presenting at the 2013 Wedbush Life Sciences Management Access Conference on Tuesday, August 13th at 8:35 AM Eastern Time at Le Parker Meridien hotel in New York City.

A live webcast of the presentation will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.

For additional information on Sunesis, please visit http://www.sunesis.com.

Investor and Media Inquiries:
David Pitts
Argot Partners
212-600-1902

Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717